Curie Therapeutics

Curie Therapeutics is discovering and developing safe, effective, and highly targeted radiopharmaceuticals. Curie is a fully integrated next generation radiopharmaceutical company that comprises experts in ligand discovery, radiochemistry, radiobiology, and oncology translational and clinical research, building a pipeline across a range of solid tumor types.

Headquarters Woburn, MA
Pipeline Status Preclinical
Twitter @CurieTx
LinkedIn Curie Therapeutics